Duopharma Biotech Records 14.52 per cent increase in revenue for nine months ended 30 September 2019
Kuala Lumpur, November 29, 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) unaudited revenue grew 14.52 per cent to RM438.71 million for nine months ended 30 September 2019 (Q3 FY2019), from RM383.09 million in the corresponding period last year, mainly due to the higher demand from private and public health sector.